PEOPLE
Experience you can rely on. At Navin Molecular, our team combine leadership qualities, extensive industry expertise and detailed scientific and manufacturing understanding to help solve your challenges.
Senior Leadership

Dr. Vijay
Kaiwar
CEO –
CDMO

Dr. Vijay Kaiwar
CEO – CDMO
Dr. Vijay Kaiwar is the CEO of the CDMO business at Navin Molecular, where he is responsible for leading strategy, operations, and growth of the company’s Contract Development and Manufacturing Organization. Based at Dewas, he drives the expansion of capabilities, customer partnerships, and technology platforms to strengthen Navin Molecular position as a trusted global partner in life sciences.
With over 30 years of experience in the CDMO and API sectors, Dr. Kaiwar brings deep expertise in R&D, technology transfer, manufacturing, operations, and commercial management. His knowledge spans advanced technologies including small and large molecules, HPAPIs, ADCs, peptides, oligonucleotides, fermentation, and probiotics, along with a strong track record of building global partnerships with leading pharmaceutical and biotech companies.
Senior Leadership

Dr. Anand
Tiwari
Head –
R&D

Dr. Anand Tiwari
Head – R&D
Dr. Anand Tiwari has extensive and diverse experience spanning over 24 years in Medicinal Chemistry, process research synthesis, process engineering, technology transfer, analytical sciences, quality and regulatory compliance, and intellectual property management. He has worked with leading organisations such as Sun Pharma, Ranbaxy, Teva API, SRF Limited, Jubilant Organosys, and Cadila Pharmaceuticals.
Throughout his career, he has successfully developed and commercialised multiple APIs across a wide range of therapeutic categories, filed numerous international patents, and led large cross-functional teams to drive sustainable innovation and commercialisation.
He is highly skilled in navigating complex regulatory landscapes and ensuring compliance with cGXP and other global regulatory requirements across geographies. His strong grasp of emerging technologies and the competitive ecosystem of differentiated product portfolios offers a unique value proposition to global customers and ensures the seamless transition of novel processes from laboratory scale to commercial manufacturing.
Dr. Anand holds a strong academic background, with a Doctor of Philosophy in Medicinal Chemistry and an M.Sc. Tech in Pharmaceutical Chemistry from the University of Lucknow.
Commercial

Ajay
Ohri
Head,
BD US

Ajay Ohri
Head, BD US
Ajay is a senior executive in the biopharma and chemical space with over 30 years’ of experience.
His industry prowess from holding global positions, managing business development teams and operations that have propagated strong international relationships.
It has enabled him to build unique business strategies with a customer centric focus driving R&D initiatives, establishing brands & commercial supply management in the biopharma and chemical space.
Commercial

Dr Matthew
Stent
Head, BD Europe
& Key Accounts

Dr Matthew Stent
Head, BD Europe & Key Accounts
Matthew heads-up our European business development team and is responsible for strategic key accounts.
He joined Navin in 2015 and set up the project management function, building an international team to manage both pre-sales (RFP evaluation and quoting) and project delivery coordination (technical oversight and customer communication), and transitioned into his current commercial role in early 2023.
Matthew is a synthetic organic chemist by training: he has a DPhil from the University of Oxford, UK, completed a Post-Doc at the University of Texas, USA, and has more than 15 years’ experience in techno-commercial roles in customer facing positions.